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A programming error on behalf of the authors led to an over
counting of baseline PTCA and CABG procedures. The error
affected Table 1 and Table 6. The correct tables are as follows:
Table 1. Baseline Demographic Data of 2,394 Patients Receiving CABG
Characteristic
Patients Deceased
During 6-Month
Follow-Up
(n  131)
Patients Alive
at 6-Month
Follow-Up
(n  2,263) p Value
Age (yr) 68.0 68.0 0.30
Gender
Male 86 (65.6%) 1,582 (69.9%) 0.35
Female 45 (34.4%) 681 (30.1%)
Race*
White 122 (93.1%) 2,129 (94.1%)
Black 6 (4.6%) 89 (3.9%) 0.90
Asian 2 (1.5%) 22 (1.0%)
Multiracial 1 (0.8%) 22 (1.0%)
BMI† (kg/m2) 27.2 27.6 0.64
Ejection fraction‡
35% 36 (39.6%) 245 (16.0%) 0.0001
35% 55 (60.4%) 1,289 (84.0%)
Myocardial infarction 90 (68.7%) 1,241 (54.8%) 0.01
Congestive heart failure 43 (32.8%) 332 (14.7%) 0.0001
Cerebrovascular disease 35 (26.7%) 328 (14.5%) 0.0001
Peripheral vascular disease 42 (32.1%) 376 (16.6%) 0.0001
Cardiac arrhythmias 48 (36.6%) 447 (19.8%) 0.0001
Insulin-dependent diabetes mellitus 25 (19.1%) 263 (11.6%) 0.05
Non–insulin-dependent diabetes mellitus 36 (27.5%) 651 (28.8%) 0.83
Diabetes, type not specified 4 (3.1%) 27 (1.2%) 0.15
Prior PTCA 18 (13.7%) 420 (18.6%) 0.20
Prior CABG 24 (18.3%) 380 (16.8%) 0.74
Method of cardioplegia delivery
(not mutually exclusive)
Anterograde 104 (84.6%) 1,944 (89.0%) 0.17
Retrograde 38 (30.9%) 984 (45.0%) 0.01
Intermittent cross-clamp 32 (26.0%) 330 (15.1%) 0.01
Type of cardioplegic solution
(not mutually exclusive)
Blood 86 (72.3%) 1,465 (68.4%) 0.43
Crystalloid 55 (46.2%) 1,160 (54.2%) 0.11
Other 11 (9.2%) 152 (7.1%) 0.48
Cardioplegia solution temperature
(not mutually exclusive)
Cold 100 (87.0%) 1,956 (91.7%) 0.11
Warm 34 (29.6%) 571 (26.8%) 0.58
Duration of cardiopulmonary bypass (min) 105 94 0.001
Total surgical time (min) 295 266 0.001
Peak CK-MB values (U/l) 36.0 17.5 0.0001
Peak CK-MB ratio 7.2 3.5 0.0001
Duration of follow-up (days) 22.0 191.0 0.0001
*Race was unknown for one patient who survived; †body mass index (BMI) was unknown for three patients who survived;
‡ejection fraction was unknown for 40 patients who died and for 729 patients who survived. Data are presented as the median
value or number (%) of patients.
CABG  coronary artery bypass graft surgery; CK-MB  creatine kinase-myocardial band isoenzymes; PTCA 
percutaneous transluminal coronary angioplasty.
1408 Corrections JACC Vol. 39, No. 8, 2002
April 17, 2002:1407–10
Wu T-J, Kim Y-H, Yashima M, Athill CA, Ting C-T,
Karagueuzian HS, Chen P-S. Progressive Action Potential
Duration Shortening and the Conversion From Atrial Flutter
to Atrial Fibrillation in the Isolated Canine Right Atrium. J
Am Coll Cardiol 2002;38:1757– 65.
There was an error in the second sentence of the legend for Figure
2. The correct sentence is as follows:
The pathway of the tip of the re-entrant wave front circled in a
counterclockwise direction (A to E) around the insertion site
of a large pectinate muscle to the underlying atrial tissue (see
Fig. 1B).
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Acid Analogue for the Evaluation of Patients With Acute
Chest Pain. J Am Coll Cardiol 2002;38:1888 –94.
The affiliation for Dr. Nagara Tamaki was incorrectly listed. Dr.
Tamaki belongs to the Department of Nuclear Medicine, Hok-
kaido University, School of Medicine, Sapporo, Japan. The correct
affiliation is: Nagara Tamaki, MD†.
The second sentence of the Results section of the Abstract was
incorrect. The correct sentence is: Of 24 patients without coronary
stenosis or spasm, 22 showed normal BMIPP SPECT (speci-
ficity  92%) and 23 showed normal tetrofosmin SPECT
(specificity  96%).
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The authors have noted an error in Table 2 and Figure 1. The
major implication is that reduction of nonfatal stroke associated
with CCB use for hypertension does not outweigh but almost
exactly balances the increase in MI. Corrected data show a relative
risk for nonfatal stroke of 0.842 (p  0.013). The relative risk for
nonfatal MI remains 1.17 (p  0.036). Respective Bonferroni-
corrected p values for nonfatal stroke and nonfatal MI are 0.052
and 0.144. In addition, in type 2 diabetics, CCBs increased major
cardiovascular events with relative risk not of 1.258 but of 1.339
(confidence intervals 1.074 to 1.670, p  0.010), thereby more
strongly supporting the provisional hypothesis that CCBs may
be less safe than ACE inhibitors in diabetics. The revised Table
2 and Figure 1 are printed here. The authors apologize for the
error.
Table 6. Final Multiple Logistic Regression Model Predicting Six-Month Mortality in Patients
Who Survived  10 Days After CABG
Characteristics Odds Ratio 95% CI p Value
Ejection fraction (35% vs. 35%) 2.93 1.65–5.22 0.001
Congestive heart failure 2.14 1.23–3.74 0.01
Peripheral vascular disease 2.25 1.35–3.75 0.01
Cardiac arrhythmias 2.39 1.45–3.95 0.001
Retrograde cardioplegia 0.33 0.19–0.59 0.001
Number of arterial bypass grafts 0.65 0.46–0.92 0.05
Peak CK-MB enzyme ratio
 5 ULN 1.00
 5 and  10 ULN 1.98 1.08–3.62 0.05
 10 and  20 ULN 2.11 1.01–4.42 0.05
 20 ULN 4.95 2.47–9.95 0.001
Abbreviations as in Tables 1 and 2.
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